Adnavance Technologies

About:

Adnavance Technologies develops direct detection molecular diagnostic tests for medical applications.

Website: http://www.adnavance.com

Top Investors: BDC Venture Capital, Business Development Bank of Canada, MDS Capital, GrowthWorks Capital, JovFunds

Description:

Adnavance Technologies is an early-stage developer of direct detection molecular diagnostic tests. The company's patented and ultra-sensitive metalized-DNA (M-DNAâ„¢) technology may eliminate the need for amplification for a large number of these tests. This technology provides many significant advantages over existing methods, including ease of use, time to result and cost. The platform is simple and inexpensive and is expected to receive FDA approval for use by any laboratory.